Sell |
Product |
CAS |
Date |
More |
Sell |
5-Methyl-2?O,4?C-methyleneuridine; LNA-5MeU |
206055-67-6 |
2022-04-21 |
|
Sell |
2?O,4?C-Methyleneuridine; LNA-U |
200435-92-3 |
2022-04-21 |
|
Sell |
N4-Methylcytidine; RNA-modified nucleoside m4C |
10578-79-7 |
2022-04-21 |
|
Sell |
2?Deoxy-5,N4,N4-trimethylcytidine |
25406-45-5 |
2022-04-21 |
|
Sell |
2?Deoxy-5,N4-dimethylcytidine |
25406-44-4 |
2022-04-21 |
|
Sell |
2?Deoxy-N4-methylcytidine |
22882-02-6 |
2022-04-21 |
|
Sell |
N3-Methylthymidine |
958-74-7 |
2022-04-21 |
|
Sell |
N3-Methyl-2?deoxyuridine |
24514-32-7 |
2022-04-21 |
|
Sell |
N3-Methyluridine; RNA-modified nucleoside m3U |
2140-69-4 |
2022-04-21 |
|
Sell |
N3-Methylcytidine; RNA-modified nucleoside m3C |
2140-64-9 |
2022-04-21 |
|
Sell |
1,3-Dimethyl pseudouridine |
64272-68-0 |
2022-04-21 |
|
Sell |
3-Methylpsedouridine; RNA-modified nucleoside m3Y |
81691-06-7 |
2022-04-21 |
|
Sell |
N1-Methylguanosine (RNA modified nucleoside) |
2140-65-0 |
2022-04-21 |
|
Sell |
7,8-Dihydro-8-oxo-7-allyl-guanosine; Loxoribine, immune-receptor, Toll-like receptor 7 (TLR7) agonist, TLR7 ligand, antitumor agent |
121288-39-9 |
2022-04-21 |
|
Sell |
N7-Methylguanosine; RNA-modified nucleoside m7G |
20244-86-4 |
2022-04-21 |
|